A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up.

Publication

A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up.

Journal Paper/Review - Nov 1, 2023

Padevit Luis, Vasella Flavio, Friedman Jason, Mutschler Valentino, Jenkins Freya Sophie, Held Ulrike, Rushing Elisabeth Jane, Wirsching Hans-Georg, Weller Michael, Regli Luca, Neidert Marian Christoph

Citation

Padevit L, Vasella F, Friedman J, Mutschler V, Jenkins F, Held U, Rushing E, Wirsching H, Weller M, Regli L, Neidert M. A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up. Front Oncol 2023; 13:1279933.

Type

Journal Paper/Review (English)

Journal

Front Oncol 2023; 13

Publication Date

Nov 1, 2023

Issn Print

2234-943X

Pages

1279933

Brief description/objective

The selection of patients for further therapy after meningioma surgery remains a challenge. Progress has been made in this setting in selecting patients that are more likely to have an aggressive disease course by using molecular tests such as gene panel sequencing and DNA methylation profiling. The aim of this study was to create a preselection tool warranting further molecular work-up.